AA
CODX

ALPS Advisors’s Co-Diagnostics CODX Stock Holding History

ALPS Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,267
Closed -$339K – 860
2021
Q4 		$339K Buy
1,267
+17
+1% +$4.46K ﹤0.01% 797
2021
Q3 		$365K Buy
1,250
+410
+49% +$120K ﹤0.01% 659
2021
Q2 		$208K Hold
840
– – ﹤0.01% 899
2021
Q1 		$240K Buy
+840
New +$335K ﹤0.01% 847

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

ALPS Advisors's CODX Position: Q1 2022 in Review

ALPS Advisors sold out of Co-Diagnostics (CODX) in Q1 2022, closing a stake of 1,267 shares — an estimated $339K sold.

ALPS Advisors first reported a position in CODX in Q1 2021 and held it in 4 quarters. The position peaked at $365K in Q3 2021. 82 funds tracked by Wall St. Rank hold CODX as of Q1 2022.

  • ALPS Advisors reported no remaining Co-Diagnostics position as of Q1 2022 after selling out during the quarter.
  • ALPS Advisors sold 1,267 Co-Diagnostics shares in Q1 2022, an estimated $339K.
  • ALPS Advisors first reported a position in Co-Diagnostics in Q1 2021 and held it in 4 quarters.
  • ALPS Advisors's Co-Diagnostics position peaked at $365K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2022.

Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.